Request Deal Involvement

Alkermes to acquire Avadel Pharmaceuticals for $2.1bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Arthur Cox

legal advisors

Arthur Cox

Morgan Stanley

financial advisors

Morgan Stanley

Goldman Sachs

financial advisors

Goldman Sachs

Goodwin Procter

legal advisors

Goodwin Procter

McCann FitzGerald

legal advisors

McCann FitzGerald

Cleary Gottlieb Steen & Hamilton

legal advisors to financial advisors

Cleary Gottlieb Steen & Hamilton

JP Morgan

financial advisors

JP Morgan

Paul Weiss Rifkind Wharton & Garrison

legal advisors

Paul Weiss Rifkind Wharton & Garrison

or

Principals

AVADEL PHARMACEUTICALS PLC

target

AVADEL PHARMACEUTICALS PLC

ALKERMES PLC

bidder

ALKERMES PLC

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite